Crossmark

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review

Crossref DOI link: https://doi.org/10.1186/s40249-022-00977-x

Published Online: 2022-05-13

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lv, Jingjing

Wu, Hui

Xu, Junjie

Liu, Jiaye https://orcid.org/0000-0003-2863-7006
License Information

Text and Data Mining valid from 2022-05-13

Version of Record valid from 2022-05-13
More Information

Article History

Received: 9 February 2022

Accepted: 18 April 2022

First Online: 13 May 2022

Declarations

:

: Not applicable.

: Not required.

: Jingjing Lv, Hu Wu, Junjie Xu, and Jiaye Liu declare that they have no conflict of interest.

Document is current

Any future updates will be listed below